U.S. FDA GRANTS PRIORITY REVIEW FOR GENENTECH’S ENSPRYNG FOR MOGAD, AN AUTOIMMUNE DISEASE WITH NO APPROVED TREATMENTS

Reuters · 2d ago

Please log in to view news